Meytag High-Tech Ventures - Investor Profile and Portfolio

NovoGI, formerly NiTi Surgical Solutions, provides medical devices for GI disease management. Offers nitinol-based compression anastomosis devices for treating patients undergoing colorectal resection procedures. CE-marked and FDA-cleared surgical devices. Its R&D, and manufacturing facilities are in Netanya, Israel and the US headquarter is in Atlanta, Georgia, and European headquarters are in Paris, and France.

AquaPure Technologies is an Israel based company which has developed a plasma-based water treatment solution for municipal wastewater and groundwater. Uses a non-thermal plasma (NTP) technology and oxidation process to remove pollutants and hazardous contaminants from wastewater.

DermiPsor was a clinical stage drug development company focused on drugs for the dermatology market. Its lead product called DPS-101 was a combination therapeutics that target multiple physiological pathways. The product has applications as a non-steroidal topical treatment for mild to moderate psoriasis. As of December 2016, the candidate has completed the phase 2b feasibility study and is planning for phase 2/3 clinical trials. In 2013, Nextgen Biomed entered into a reverse merger with DermiPsor & has acquired 98.6% of its stake.

Provider of third-party logistics, contract packing, and promotional marketing services. This company offers end-to-end solutions for managing and fulfilling campaigns and orders. Services include warehousing, distribution, dangerous goods handling, print management, multi-channel customer service, and reverse logistics. They utilize a warehouse management system and 3PL process automation for efficient operations. The company works with a variety of clients across various sectors, providing tailored solutions to meet specific needs. Their services aim to improve efficiency, speed, and sustainability for clients' projects.